MORE►
Alzheimer’s disease
The leadership team for UT Southwestern's new North Texas Alzheimer's Disease Research Center includes principal investigator Dr. Ihab Hajjar (left), O'Donnell Brain Institute director Dr. William Dauer, and neurology chair Dr. Elan Louis. Their work will push the frontier of dementia research, as well as support community outreach and training for caregivers. [Photos: UT Southwestern Medical Center]
NIH Taps UT Southwestern Medical Center for $23M North Texas Alzheimer’s Disease Research Hub
by Quincy Preston | Sep 3, 2025
The new federal Alzheimer's hub joins an elite network of 37 centers nationwide. Scientists from UT Southwestern, UT Arlington, and UT Dallas will decode dementia by exploring hypertension's role, analyzing voice patterns with AI, and creating virtual patient models.
by David Seeley |
Mar 18, 2025
"The launch of ZUNVEYL is a game-changer in our fight against Alzheimer’s disease," said Lauren D’Angelo, COO and chief commercial officer at Alpha Cognition. The drug is designed to provide "a differentiated treatment option" for patients with mild-to-moderate Alzheimer’s diagnoses.
MORE►
by David Seeley |
Jan 9, 2025
Alpha Cognition’s Alzheimer’s oral therapy ZUNVEYL, FDA-approved in July, targets U.S. launch in Q1 2025 as the company boosts its commercialization team with five new hires.
MORE►
by Lance Murray |
Nov 5, 2024
UTD psychology professors Karen Rodrigue and Kristen Kennedy will use one of the most powerful imaging machines in existence—the 24-ton 7-Tesla magnetic resonance scanner—to identify the major brain differences between younger and older adults.
MORE►
[Image: sudok1/istockphoto]
Alpha Cognition Gets FDA Acceptance of New Alzheimer’s Drug Application
by David Seeley | Dec 13, 2023
Based in Vancouver with a North Texas office in Frisco, Alpha Cognition said its novel oral tablet ALPHA-1062 is designed for the treatment of people with mild to moderate Alzheimer's disease. The company was honored at the recent BioNTX iC3 Summit as one of eight "Rising Stars."
MORE►
by David Seeley |
Apr 17, 2023
Subtle changes in the way people speak could help doctors diagnose cognitive impairment and Alzheimer’s disease—even before symptoms begin to show. That's according to a new study led UT Southwestern researcher Ihab Hajjar, M.D., working with a research team at Emory University in Atlanta. After being given standard cognitive assessments, 206 participants were asked to talk about an art work. Here's what happened next.
MORE►
by Lance Murray |
Mar 9, 2023
Rebelution CEO Melonie Carnegie will chair the fourth annual Gala, An Event to Remember, hosted by the Dallas and Northeast Texas Chapter of the Alzheimer’s Association on April 29 at the Arts District Mansion....
MORE►
by Lance Murray |
Jan 27, 2023
The foundation—launched in the early 1990s by Fort Worth billionaire and philanthropist Richard E. Rainwater—said that this year's $400K Outstanding Innovation Prize will be awarded to a team from the University of California San Diego and Washington University.
Dr. Susanne Wegmann of the German Center for Neurodegenerative Diseases (DZNE) will be awarded the $200K Rainwater Prize for Innovative Early-Career Scientist.
MORE►
Sid O’Bryant, professor and executive director of the HSC Institute for Translational Research. [Photo: HSC]
‘We Are Going to Change the World’: $150M Grant Fuels UNT Health Science Center’s Diversity-Focused Alzheimer’s Research
by Kevin Cummings | Oct 3, 2022
The funding from the National Institutes of Health will help UNT HSC at Fort Worth advance its ongoing research on how Alzheimer's disease affects different racial and ethnic groups. Sid O'Bryant, executive director of UNT HSC's Institute for Translational Research, said there's never been a large-scale study like this before.
“This award and project are nothing short of a bio behavioral ‘moonshot’ program," adds Brian Gladue, HSC executive VP for research and innovation.
MORE►
by Sandra Engelland |
Mar 16, 2021
Contracting Alzheimer's is the No. 1 fear of people over 65, says Sid O'Bryant, who wants to give primary physicians the ability to test for Alzheimer's with a blood test. That can offer peace of mind to many and earlier help for those who need it.
His groundbreaking research, which has revealed significant differences in biomarkers for the disease, could make the treatment of Alzheimer's more like that for cancer—a multi-dimensional "precision" approach.
His groundbreaking research, which has revealed significant differences in biomarkers for the disease, could make the treatment of Alzheimer's more like that for cancer—a multi-dimensional "precision" approach.
MORE►
by Lance Murray |
Sep 20, 2019
In this weekly roundup of research and development activity in North Texas, you'll also find news about a UT Southwestern study on how exercise may slow brain deterioration for those at risk of Alzheimer's disease.
MORE►
by Lance Murray |
Jan 25, 2019
You’ll also find out about how research at the University of Texas at Dallas may help determine who is at high risk for Alzheimer’s disease in this roundup of research and development activity in North Texas.
MORE►
[Illustration: IconicBestiary via iStock]
R&D: UTSW Works on Alzheimer’s Prevention Drug; UTA prof tackles pipeline leaks
by Lance Murray | Jan 4, 2019
You'll also find out about an SMU physicist who's been named a fellow in a prestigious science group in the roundup of research and development activity in North Texas.
MORE►
by Lance Murray |
Nov 9, 2018
Also, you'll learn about the Dallas-based American Heart Association backing research teams looking into age-related cognitive declines, and a Plano-based biotech company getting an approval from the EPA.
MORE►
by Lance Murray |
Oct 26, 2018
Also, you'll learn about how two schools are splitting a National Cancer Institute grant to study cancer health disparity and how TWU plans to show off its research. Here are some of the research projects underway in North Texas that could make lives better.
MORE►
by Lance Murray |
Oct 5, 2018
Also, you'll learn about a researcher who's studying the effects of even mild traumatic brain injuries on veterans. Here are some of the research projects underway in North Texas that could make lives better.
MORE►
![Erica Kosemund, Chief Brand Officer, Choctaw Nation of Oklahoma; Gillian Breidenbach, Chief Partnership Officer, North Texas FWC Organizing Committee; Chief Gary Batton, Chief of Choctaw Nation of Oklahoma; Monica Paul, Executive Director of Dallas Sports Commission and President of North Texas FWC Organizing Committee; John Hobbs, Senior Executive Officer of Communications, Choctaw Nation of Oklahoma; and Heidi Grant, Senior Executive Officer of Commerce Administration, Choctaw Nation of Oklahoma, celebrate Choctaw Casinos & Resorts becoming an Official Dallas World Cup 2026 Host City Supporter. [Photo: North Texas FWC Organizing Committee/Choctaw Casinos & Resorts]](https://s24806.pcdn.co/wp-content/uploads/2025/12/FIFA-Choctaw-dec-2025.jpg)
